在喘中过度使用短效β2agonists (SABA),以及患者对这种行为的看法
Claire D Visser1, Maaike R A Faay1, Ayşe Özdemir1
1Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, the Netherlands.
Respiratory medicine
|June 27, 2024
概括
短效β2抗体 (SABA) 的过度使用在五分之一的荷兰喘患者中持续存在,这表明需要专业的注意. 药房发行数据有效地识别了SABA的过度使用,指导了为更好的喘控制量身定制的干预措施.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 临床药房 临床药房
- 行为科学 行为科学
背景情况:
- 过度使用短效β2-激动剂 (SABA) 与喘控制不良有关.
- 全球喘倡议 (GINA) 战略已经改变了缓解治疗的建议.
研究的目的:
- 在荷兰的喘患者中调查SABA过度使用和分发模式.
- 验证药房发行数据以识别SABA过度使用.
- 了解患者对SABA使用的观点,以告知干预措施.
主要方法:
- 一项为期5年的 (2017-2021) 横截面研究,使用药房发行数据.
- 用问卷和采访对发现SABA过度使用的患者进行定性研究.
- 使用理论框架分析行为驱动因素.
主要成果:
- 在2017-2021年期间,SABA过度使用的流行率保持不变,为20.6%.
- 药房发行数据显示,SABA过度使用的积极预测值为81%.
- 七个主题确定了患者的能力,动机和机会作为关键的行为驱动因素.
结论:
- 过度使用SABA影响了荷兰五分之一的喘患者,需要医疗保健专业人员的注意.
- 分发数据是识别SABA过度使用和选择患者进行干预的有效工具.
- 量身定制的行为干预措施对于解决各种患者需求和改善喘管理至关重要.
相关概念视频
Antiasthma Drugs: β2-Adrenoceptor Agonists
245
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
245
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Drugs Used in Lower Respiratory Disorders: Overview
402
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
402
Adrenergic Agonists: Therapeutic Uses
764
Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
764
Antiasthma Drugs: Muscarinic Receptor Antagonists
283
Muscarinic receptor antagonists, also known as antimuscarinic agents, are a class of bronchodilators used to treat asthma, although they are more commonly used to treat COPD. They work by inhibiting the action of acetylcholine (ACh), a neurotransmitter, on muscarinic receptors found in the airways.
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
283
Inhaled Medications
250
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
250


